Results 261 to 270 of about 140,500 (312)
Plasma Desmosine Is Elevated in Thoracoabdominal Aortic Aneurysms and Is Associated with Intramural Proteolytic Activity. [PDF]
Int J Mol SciDoukas P +10 more
europepmc +1 more source
Early plasma changes of HIF-1 alpha, matrix metalloproteinases-2 and - 9, and tissue inhibitor of matrix metalloproteinase-1 in patients with infantile hemangiomas treated with propranolol. [PDF]
Pharmacol RepKowalska M +5 more
europepmc +1 more source
The ADAMTS family: from extracellular matrix proteases to orchestrators of fibrosis. [PDF]
Cell Commun SignalYuan Y, Guo P, Song Y, Yu Z, Song B.
europepmc +1 more source
Role of exosome therapy in reconstructive surgery: a review. [PDF]
Front Med (Lausanne)Arkoubi AY.
europepmc +1 more source
Polymorphisms of the <i>MMP2</i> and <i>MMP9</i> genes in the development of aortic aneurysm in patients with bicuspid aortic valve. [PDF]
Turk Gogus Kalp Damar Cerrahisi DergAlur İ +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical and Experimental Pharmacology and Physiology, 2010
Summary1. Matrix metalloproteinases (MMP) are associated with the vascular remodelling seen in atherosclerosis and aneurysm. The activation and activity of MMP‐2 are regulated by the intrinsic tissue inhibitor of MMP‐2 (TIMP‐2). The aim of the present study was to examine whether, conversely, MMP‐2 can affect the gene and protein expression of TIMP‐2.2.
Kaoru, Kimura +9 more
openaire +2 more sources
Summary1. Matrix metalloproteinases (MMP) are associated with the vascular remodelling seen in atherosclerosis and aneurysm. The activation and activity of MMP‐2 are regulated by the intrinsic tissue inhibitor of MMP‐2 (TIMP‐2). The aim of the present study was to examine whether, conversely, MMP‐2 can affect the gene and protein expression of TIMP‐2.2.
Kaoru, Kimura +9 more
openaire +2 more sources